Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Biolase Technology, Inc. (NQ: BIOL)
4.720 USD  UNCHANGED
Official Closing Price  /  Updated: 8:10 PM EDT, May 21, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Biolase Technology, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
BIOLASE Files Amendment to 2011 Form 10-K to Update Exhibit 10.32 Associated With Henry Schein Settlement Agreement
July 09, 2012
Amendment Does Not Change Company's Audited 2011 Financial Statements; Discloses Previously Redacted Per-Unit Repurchase Price of Waterlase MD(TM) Turbo Laser System Read More
from Marketwired News Releases
BIOLASE Comments on Recent Market Activity
June 22, 2012
Believes Only Reason for the Recent Weakness in Its Stock Price Is the Re-Balancing of the Russell 3000 Index Read More
from Marketwired News Releases
BIOLASE Waterlase iPlus(TM) All-Tissue Dental Laser System Wins Awards for High-Tech Innovation and Medical Design
June 18, 2012
Honored by TechAmerica, Medical Design Excellence Awards(R) Read More
from Marketwired News Releases
BIOLASE Secures $8 Million Revolving Credit Facility
May 29, 2012
from Marketwired News Releases
BIOLASE New Ticker Symbol Effective Today
May 29, 2012
from Marketwired News Releases
BIOLASE Changes Ticker Symbol to BIOL
May 21, 2012
from Marketwired News Releases
BIOLASE Holds Annual Meeting of Stockholders
May 11, 2012
from Marketwired News Releases
BIOLASE Reports First Quarter Results
May 09, 2012
from Marketwired News Releases
BIOLASE to Present at Upcoming Investment Conferences
May 08, 2012
from Marketwired News Releases
BIOLASE Introduces Next Generation Diode Laser, the EPIC 10(TM)
May 04, 2012
from Marketwired News Releases
BIOLASE Conference Call: 2012 First Quarter Results
May 02, 2012
BIOLASE to Host Conference Call, May 9th at 4:30 p.m. E.T. Read More
from Marketwired News Releases
BIOLASE Responds to Patent Action
April 30, 2012
ezlase(R) Sales Move Forward Worldwide Read More
from Marketwired News Releases
BIOLASE Files Patent Infringement Lawsuit Against European Competitor
April 25, 2012
from Marketwired News Releases
BIOLASE Completes Transaction With Henry Schein
April 16, 2012
from Marketwired News Releases
BIOLASE Expects Revenue for the 2012 First Quarter to Be Approximately $12 Million, Up From Previous Guidance of $11 Million
April 16, 2012
Year-Over-Year Normalized Revenue Up 58 Percent Read More
from Marketwired News Releases
BIOLASE to Present at the 11th Annual Needham Healthcare Conference
April 02, 2012
from Marketwired News Releases
BIOLASE Reports Fourth Quarter, Year-End Results
March 08, 2012
from Marketwired News Releases
BIOLASE Chief Executive Officer to Continue at Rate of $1.00 Annual Salary
March 08, 2012
from Marketwired News Releases
BIOLASE Announces Appointment of William E. Brown to Vice President, Sales & Marketing
March 08, 2012
from Marketwired News Releases
BIOLASE Declares Stock Dividend for 2012 First Quarter
March 05, 2012
Sets March 15, 2012 as Record Date; Board Approves a Two Percent Annual Stock Dividend Policy Read More
from Marketwired News Releases
BIOLASE Announces Preliminary Fourth Quarter Results
February 28, 2012
Unaudited GAAP Revenue in Q4 Is Expected to Total Approximately $13.1 Million, up 35 Percent Year Over Year; Unaudited GAAP Revenue in 2011 Is Expected to Total Approximately $48.8 Million, up 86... Read More
from Marketwired News Releases
BIOLASE Announces Agreement With Henry Schein for the Purchase of the Remaining Inventory of Hard-Tissue Lasers, the Waterlase MD(TM) Turbo
February 28, 2012
Schein to Release All Liens on BIOLASE Assets, Upon Closing, as All Obligations of Repayment of Advanced Purchases Have Been Entirely Fulfilled Read More
from Marketwired News Releases
BIOLASE Announces the Introduction of the Waterlase MDX(TM) Line of All-Tissue Lasers at the Chicago Dental Society Midwinter Meeting
February 24, 2012
The Mid-Level MDX 450 and Entry-Level MDX 300 Expand BIOLASE's All-Tissue Product Portfolio and Complement the Market Leading Waterlase iPlus(TM) Read More
from Marketwired News Releases
BIOLASE and Cefla Dental Group Announce Exclusive Distribution Agreement
February 23, 2012
BIOLASE to Sell High-End NewTom Cone Beam 3D Imaging Products in North America Read More
from Marketwired News Releases
BIOLASE Signs Strategic Sales and Marketing Partnership With the Seattle Study Club, a Leading Dental Education Organization
January 27, 2012
from Marketwired News Releases
BIOLASE Issued Broad New Patent for Treating Eye Conditions, Including Presbyopia, Cataracts and Glaucoma
November 30, 2011
Additional Support for Ophthalmic Applications Using the Company's Er,Cr:YSGG OCCULASE MD(TM) Technology Read More
from Marketwired News Releases
BIOLASE to Present at Upcoming Investment Conferences
November 29, 2011
from Marketwired News Releases
BIOLASE Declares Stock Dividend for 2011 Fourth Quarter
November 15, 2011
Sets November 25, 2011 as Record Date Read More
from Marketwired News Releases
BIOLASE to Present at Lazard Capital Markets Healthcare Conference
November 09, 2011
from Marketwired News Releases
BIOLASE Granted Regulatory Approval to Sell Waterlase iPlus(TM) All-Tissue Dental Laser Systems in South Korea
November 08, 2011
from Marketwired News Releases
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here